Align Technology, Inc. (ALGN)’s director Thomas Prescott Sold 82000 shares of the Company; Constellium N.V. Ordinary Shares (CSTM) Sellers Increased By 8.36% Their Shorts

Constellium N.V. (NYSE:CSTM) Logo

Constellium N.V. Ordinary Shares (NYSE:CSTM) had an increase of 8.36% in short interest. CSTM’s SI was 592,100 shares in May as released by FINRA. Its up 8.36% from 546,400 shares previously. With 1.14 million avg volume, 1 days are for Constellium N.V. Ordinary Shares (NYSE:CSTM)’s short sellers to cover CSTM’s short positions. The SI to Constellium N.V. Ordinary Shares’s float is 0.57%. The stock decreased 1.76% or $0.2 during the last trading session, reaching $11.15. About 864,124 shares traded. Constellium N.V. (NYSE:CSTM) has risen 63.85% since May 2, 2017 and is uptrending. It has outperformed by 52.30% the S&P500.

Constellium N.V. engages in the design, manufacture, and sale of specialty rolled and extruded aluminum products for the aerospace, packaging, and automotive end-markets. The company has market cap of $1.50 billion. The firm operates in three divisions: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry. It currently has negative earnings. The Packaging & Automotive Rolled Products segment produces rolled aluminum products, including can stock and closure stock for the beverage and food industry, and foil stock for the flexible packaging market.

Among 13 analysts covering Constellium NV (NYSE:CSTM), 10 have Buy rating, 0 Sell and 3 Hold. Therefore 77% are positive. Constellium NV has $20.0 highest and $600 lowest target. $13.25’s average target is 18.83% above currents $11.15 stock price. Constellium NV had 29 analyst reports since August 6, 2015 according to SRatingsIntel. BMO Capital Markets maintained the stock with “Market Perform” rating in Friday, October 27 report. The firm has “Overweight” rating given on Tuesday, February 6 by Morgan Stanley. Seaport Global upgraded the shares of CSTM in report on Wednesday, November 23 to “Buy” rating. On Friday, October 2 the stock rating was maintained by Sterne Agee CRT with “Buy”. The stock has “Buy” rating by Deutsche Bank on Thursday, August 6. Deutsche Bank maintained the stock with “Buy” rating in Monday, October 5 report. On Wednesday, February 28 the stock rating was maintained by Morgan Stanley with “Overweight”. The firm has “Buy” rating given on Tuesday, February 6 by Cowen & Co. The stock of Constellium N.V. (NYSE:CSTM) has “Market Perform” rating given on Monday, September 21 by Cowen & Co. The firm has “Outperform” rating by Cowen & Co given on Monday, November 27.

Align Technology Inc’s director, Thomas Prescott, made a sale of 82,000 shares of stock in the Pinksheet-listed Align Technology Inc. The reported average cost per share was $252.8, for full deal sum of $20,725,786 US Dollars. This substantial deal was reported on May 1, 2018 and is readily available on the SEC’s website. The odds that this sell remains undiscovered is very low because of the large amount of cash involved. Right now, Thomas Prescott owns 140,399 shares which are equivalent to about 0.18% of the company’s total market capitalization.

Align Technology, Inc. designs, manufactures, and markets a system of clear aligner therapy, intra-oral scanners, and computer-aided design and computer-aided manufacturing digital services. The company has market cap of $20.14 billion. The company's Clear Aligner segment offers Invisalign Full, a treatment used for a range of malocclusion; Invisalign Teen treatment that addresses orthodontic needs of teenage patients, such as compliance indicators, compensation for tooth eruption, and six free single arch replacement aligners; and Invisalign Assist treatment for anterior alignment and aesthetically-oriented cases. It has a 88.81 P/E ratio. It also provides Invisalign Express (10 and 5) and Invisalign Lite/i7 treatments for orthodontic cases, non-comprehensive treatment relapse cases, or straightening prior to restorative or cosmetic treatments; Invisalign Go, a solution for general practitioner dentists (GPs) to identify and treat patients with mild malocclusion; SmileDirectClub aligners for minor tooth movement; custom clear aligner retainers used to maintain tooth position and correct minor relapse; and SmartTrack, a custom-engineered material that delivers force for orthodontic tooth movements.

Among 15 analysts covering Align Technology (NASDAQ:ALGN), 12 have Buy rating, 0 Sell and 3 Hold. Therefore 80% are positive. Align Technology has $320 highest and $72 lowest target. $259.29’s average target is 3.16% above currents $251.34 stock price. Align Technology had 62 analyst reports since July 27, 2015 according to SRatingsIntel. As per Wednesday, October 18, the company rating was maintained by Robert W. Baird. The rating was upgraded by Bank of America to “Buy” on Friday, July 28. The firm has “Buy” rating by Stifel Nicolaus given on Tuesday, January 30. Credit Suisse maintained it with “Buy” rating and $29000 target in Friday, April 6 report. Robert W. Baird downgraded the shares of ALGN in report on Monday, October 3 to “Neutral” rating. The rating was maintained by Stifel Nicolaus with “Buy” on Friday, June 23. Leerink Swann maintained the stock with “Outperform” rating in Friday, July 28 report. The firm has “Overweight” rating given on Thursday, April 26 by Barclays Capital. As per Friday, January 19, the company rating was downgraded by Stephens. The rating was maintained by Jefferies with “Buy” on Wednesday, September 13.

The stock increased 0.60% or $1.49 during the last trading session, reaching $251.34. About 535,314 shares traded. Align Technology, Inc. (NASDAQ:ALGN) has risen 117.77% since May 2, 2017 and is uptrending. It has outperformed by 106.22% the S&P500.

Since February 2, 2018, it had 1 insider buy, and 1 insider sale for $11.56 million activity. Wright Emory sold $11.91M worth of stock. 1,500 shares were bought by HOGAN JOSEPH M, worth $350,445 on Tuesday, February 13.

Investors sentiment is 0.93 in 2017 Q4. Its the same as in 2017Q3. It is without change, as 37 investors sold Align Technology, Inc. shares while 216 reduced holdings. only 100 funds opened positions while 136 raised stakes. 60.90 million shares or 3.22% less from 62.92 million shares in 2017Q3 were reported. Stifel Fin Corporation reported 55,345 shares. Moreover, Amalgamated Financial Bank has 0.06% invested in Align Technology, Inc. (NASDAQ:ALGN). Marvin And Palmer Incorporated holds 4.18% or 18,144 shares. Melvin Capital Mngmt Lp has invested 0.35% in Align Technology, Inc. (NASDAQ:ALGN). Fulton Natl Bank Na owns 2,370 shares. Gam Ag reported 0.04% in Align Technology, Inc. (NASDAQ:ALGN). Martin Currie Ltd reported 2,800 shares. Guggenheim Capital Ltd has invested 0.2% in Align Technology, Inc. (NASDAQ:ALGN). Virginia Retirement Et Al reported 0.25% of its portfolio in Align Technology, Inc. (NASDAQ:ALGN). Cipher Capital Lp reported 0.02% in Align Technology, Inc. (NASDAQ:ALGN). California State Teachers Retirement System has invested 0.06% in Align Technology, Inc. (NASDAQ:ALGN). New York-based Art Advsr Limited Liability has invested 0.06% in Align Technology, Inc. (NASDAQ:ALGN). Susquehanna Group Incorporated Ltd Liability Partnership accumulated 106,107 shares. Geode Cap Ltd Com has invested 0.07% of its portfolio in Align Technology, Inc. (NASDAQ:ALGN). Parkwood holds 1,089 shares.

Align Technology, Inc. (NASDAQ:ALGN) Institutional Positions Chart